表紙
市場調查報告書

骨移植片及人工骨骼替代物市場規模與預測:各材料(自體移植片,異體移植片,合成移植片-陶瓷,複合材料,聚合物,骨形成蛋白),各用途,及預測

Bone Grafts And Substitutes Market Size, Share & Trends Analysis Report By Material Type (Allograft, Synthetic), By Application Type (Spinal Fusion, Craniomaxillofacial, Long Bone), By Region, And Segment Forecasts, 2019 - 2026

出版商 Grand View Research, Inc. 商品編碼 398861
出版日期 內容資訊 英文 126 Pages
商品交期: 2-3個工作天內
價格
骨移植片及人工骨骼替代物市場規模與預測:各材料(自體移植片,異體移植片,合成移植片-陶瓷,複合材料,聚合物,骨形成蛋白),各用途,及預測 Bone Grafts And Substitutes Market Size, Share & Trends Analysis Report By Material Type (Allograft, Synthetic), By Application Type (Spinal Fusion, Craniomaxillofacial, Long Bone), By Region, And Segment Forecasts, 2019 - 2026
出版日期: 2019年11月28日內容資訊: 英文 126 Pages
簡介

本報告提供骨移植片及人工骨骼替代物市場相關調查,市場趨勢與各材料,各用途,及各地區預測,競爭趨勢,及加入此市場的主要企業簡介等彙整資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場概要

第4章 市場變數,趨勢,範圍

  • 市場區隔和範圍
    • 促進要素分析
    • 阻礙要素分析
  • 滲透率與成長預測製圖
  • SWOT分析
  • 波特五力分析

第5章 市場類別1:各材料預測與趨勢分析

  • 各材料趨勢分析與市場佔有率
  • 天然
    • 自體移植片
    • 異體移植片
    • 合成
    • 陶瓷
    • 複合材料
    • 聚合物
    • 骨形成蛋白(BMP)

第6章 市場類別2:各用途預測與趨勢分析

  • 各用途趨勢分析與市場佔有率
  • 顱顏面
  • 牙科
  • 腳·腳踝
  • 關節重建
  • 長骨
  • 脊椎融合

第7章 市場類別3:各地區預測與趨勢分析

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 競爭環境

  • 策略性架構
  • 企業簡介
    • Allosource
    • Baxter
    • Depuy Synthese,Inc
    • Medtronic
    • Nuvasive, Inc
    • Orthofix Holdings,Inc
    • Orthovita, Inc
    • Smith & Nephew, Inc
    • Stryker Corporation
    • Wright Medical Group N.V

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-1-68038-154-2

The global bone grafts & substitutes market size is expected to reach USD 3.54 billion by 2026, according to a new report by Grand View Research, Inc. The market is expected to register a healthy CAGR of 4.1% during the forecast period. The availability of advanced products in varied shapes and sizes providing high osteoconductive and osteoinductive properties is supplementing market growth. In minimally invasive procedures, large incisions and damage to muscles surrounding repair area can be significantly avoided. These techniques also reduce the duration of hospital stay and support rapid wound healing with lesser pain and surgical wounds. Thus, rising adoption of bone graft and substitutes in minimally invasive surgical procedures is further anticipated to boost market growth in near future.

Minimally invasive total joint replacement and spine surgeries are some of the newly adopted procedures. Moreover, increasing adoption of synthetic bone grafts due to lesser chance of disease transmission is propelling the growth. Key companies operational in the bone grafts and substitutes market space are DePuy Synthes; Medtronic PLC; NuVasive, Inc.; Orthofix Holdings, Inc.; Wright Medical Group N.V.; AlloSource, Inc.; and Stryker Corp.

Further key findings from the report suggest:

  • Increasing number of orthopedic surgeries and rising demand for minimally invasive surgeries are primary factors driving the growth
  • By product type, allografts accounted for the largest revenue share as of 2018 in bone grafts & substitutes market, mainly due to properties such as immediate structural support and osteoconductivity. Moreover, allografts do not require another surgery to harvest the bone, which results in reduced surgery time and wound healing, thus, attributing toward segment growth
  • Spinal segment held the largest share of the application segment in 2018 owing to the increasing geriatric population and growing number of spinal disorders.
  • The dental segment is expected to exhibit the fastest growth over the forecast period owing to the increasing number of dental implant surgeries and technological advancements in dental grafts.
  • The U.S. held dominant revenue share of North American market in 2018, owing to rising traumatic injuries, adoption of bone grafts, and number of orthopedic & minimally invasive surgical procedures

Key players in the market include: DePuy Synthes; Medtronic PLC; Nuvasive, Inc.; Orthofix Holdings, Inc.; Wright Medical Group N.V.; AlloSource, Inc.; and Stryker Corp.

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details of Primary Research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.2 Data for primary interviews in Europe
      • 1.3.5.3 Data for primary interviews in Asia Pacific
      • 1.3.5.4 Data for primary interviews in Middle East and Africa
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 Abbreviations
  • 1.10 Report Objectives

Chapter 2 Executive Summary

  • 2.1 Market Outlook
    • 2.1.1 Bone Grafts & Substitutes market Outlook, 2014 - 2026 (USD Million)
  • 2.2 Bone Grafts & Substitutes Market Summary, 2018

Chapter 3 Bone Grafts & Substitutes Market Variables, Trends & Scope

  • 3.1 Technology Timeline Overview
    • 3.1.1 Technology Timeline Bone Grafts & Substitutes changing technology & adoption
  • 3.2 Regulatory Framework
  • 3.3 FDA Consideration
    • 3.3.1 Bone grafts & substitutes that found to be medically necessary
  • 3.4 Reimbursement framework
    • 3.4.1 CPT Coding
    • 3.4.2 HCPCS Coding
  • 3.5 Bone Grafts & Substitutes Market Dynamics
    • 3.5.1 Market driver analysis
      • 3.5.1.1 Rising incidence of bone & joint disorders
      • 3.5.1.2 Advent of biocompatible synthetic graft
      • 3.5.1.3 Rising demand for dental bone grafts
      • 3.5.1.4 Technological advancement
      • 3.5.1.5 Rising geriatric population
    • 3.5.2 Market restraint analysis
      • 3.5.2.1 Stringent regulatory guidelines
      • 3.5.2.2 Risk of disease transmission
      • 3.5.2.3 High cost of bone grafts and substitutes
  • 3.6 Bone Grafts & Substitutes Market Analysis Tools: Porters
    • 3.6.1 Supplier POWER: Low
    • 3.6.2 Buyer POWER: - high
    • 3.6.3 THREAT OF SUBSTITUTES: moderate
    • 3.6.4 THREAT OF NEW ENTRANTS: high
    • 3.6.5 Competitive Rivalry: high
  • 3.7 PESTEL Analysis
    • 3.7.1 Political Landscape
    • 3.7.2 Economic Landscape
    • 3.7.3 Technology Landscape
    • 3.7.4 Social Landscape

Chapter 4 Bone Grafts & Substitutes Market: Competitive Analysis

  • 4.1 Innovators
  • 4.2 Key Company Market Share Analysis, 2018
  • 4.3 Market Leaders
  • 4.4 Market Leaders By Product Segment
  • 4.5 Major Deals & Strategic Alliances Analysis
    • 4.5.1 product launch
    • 4.5.2 Acquisitions
    • 4.5.3 Product Approval
    • 4.5.4 Partnership & Collaborations

Chapter 5 Bone Grafts & Substitutes Market: Product Estimates & Trend Analysis

  • 5.1 Product Market Share Analysis, 2018 & 2026
  • 5.2 Product Dashboard
    • 5.2.1 Allograft
      • 5.2.1.1 Allograft market estimates and forecasts, 2014 - 2026 (USD Million)
      • 5.2.1.2 Demineralized Bone Matrix (DBM)
      • 5.2.1.3 Demineralized Bone Matrix (DBM) market estimates and forecasts, 2014 - 2026 (USD Million)
      • 5.2.1.4 Others
      • 5.2.1.5 Others market estimates and forecasts, 2014 - 2026 (USD Million)
    • 5.2.2 Synthetic
      • 5.2.2.1 Synthetic market estimates and forecasts, 2014 - 2026 (USD Million)
      • 5.2.2.2 Ceramic
      • 5.2.2.3 Ceramic market estimates and forecasts, 2014 - 2026 (USD Million)
      • 5.2.2.4 HAP
      • 5.2.2.5 HAP market estimates and forecasts, 2014 - 2026 (USD Million)
      • 5.2.2.6 B-TCP
      • 5.2.2.7 B-TCP market estimates and forecasts, 2014 - 2026 (USD Million)
      • 5.2.2.8 α-tricalcium phosphate (α-TCP)
      • 5.2.2.9 A-TCP market estimates and forecasts, 2014 - 2026 (USD Million)
      • 5.2.2.10 Bi-phasic calcium phosphates (BCP)
      • 5.2.2.11 Bi-phasic calcium phosphates (BCP) market estimates and forecasts, 2014 - 2026 (USD Million)
      • 5.2.2.12 Others
      • 5.2.2.13 thers market estimates and forecasts, 2014 - 2026 (USD Million)
      • 5.2.2.14 Composite
      • 5.2.2.15 Composite market estimates and forecasts, 2014 - 2026 (USD Million)
      • 5.2.2.16 Polymers
      • 5.2.2.17 Polymers market estimates and forecasts, 2014 - 2026 (USD Million)
      • 5.2.2.18 BMP
      • 5.2.2.19 BMP market estimates and forecasts, 2014 - 2026 (USD Million)

Chapter 6 Bone Grafts & Substitutes Market: Application Estimates & Trend Analysis

  • 6.1 Application Market Share Analysis, 2018 & 2026
  • 6.2 Application Dashboard
  • 6.3 Craniomaxillofacial
    • 6.3.1 Craniomaxillofacial market estimates and forecasts, 2014 - 2026 (USD Million)
  • 6.4 Dental
    • 6.4.1 Dental market estimates and forecasts, 2014 - 2026 (USD Million)
  • 6.5 Foot & Ankle
    • 6.5.1 Foot & Ankle market estimates and forecasts, 2014 - 2026 (USD Million)
  • 6.6 Joint Reconstruction
    • 6.6.1 Joint Reconstruction market estimates and forecasts, 2014 - 2026 (USD Million)
  • 6.7 Long Bone
    • 6.7.1 Long Bone market estimates and forecasts, 2014 - 2026 (USD Million)
  • 6.8 Spinal Fusion
    • 6.8.1 Spinal Fusion market estimates and forecasts, 2014 - 2026 (USD Million)

Chapter 7 Bone Grafts & Substitutes Market: Regional Estimates & Trend Analysis, By, Product, Application, And End-Use

  • 7.1 Regional Market Snapshot
  • 7.2 North America
    • 7.2.1 North America Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026(USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026(USD Million)
  • 7.3 Europe
    • 7.3.1 Europe Bone Grafts & Substitutes MARKET estimates and forecasts, 2014 - 2026 (USD Million)
    • 7.3.2 UK
      • 7.3.2.1 UK Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026(USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Germany Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 France Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
    • 7.4.5 South Korea
      • 7.4.5.1 South Korea Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
    • 7.5.2 Mexico
      • 7.5.2.1 Mexico Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
    • 7.5.3 Brazil
      • 7.5.3.1 Brazil Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa Bone Grafts & Substitutes market estimates and forecasts, 2014 - 2026 (USD Million)

Chapter 8 Company Profiles

  • 8.1 AlloSource
    • 8.1.1 Company overview
    • 8.1.2 Product benchmarking
    • 8.1.3 Strategic Initiatives
  • 8.2 Baxter
    • 8.2.1 Company overview
    • 8.2.2 Financial Performance
    • 8.2.3 Product benchmarking
    • 8.2.4 Strategic Initiatives
  • 8.3 DePuy Synthes, Inc.
    • 8.3.1 Company overview
    • 8.3.2 Financial Performance
    • 8.3.3 Product benchmarking
    • 8.3.4 Strategic Initiatives
  • 8.4 Medtronic
    • 8.4.1 Company overview
    • 8.4.2 Financial Performance
    • 8.4.3 Product benchmarking
    • 8.4.4 Strategic Initiatives
  • 8.5 Nuvasive, Inc.
    • 8.5.1 Company overview
    • 8.5.2 Financial Performance
    • 8.5.3 Product benchmarking
    • 8.5.4 Strategic Initiatives
  • 8.6 Orthofix Holdings, Inc.
    • 8.6.1 Company overview
    • 8.6.2 Financial Performance
    • 8.6.3 Product benchmarking
    • 8.6.4 Strategic Initiatives
  • 8.7 Smith & Nephew, Inc.
    • 8.7.1 Company overview
    • 8.7.2 Financial Performance
    • 8.7.3 Product benchmarking
    • 8.7.4 Strategic Initiatives
  • 8.8 Stryker Corporation
    • 8.8.1 Company overview
    • 8.8.2 Financial Performance
    • 8.8.3 Product benchmarking
    • 8.8.4 Strategic Initiatives
  • 8.9 Wright Medical Group N.V.
    • 8.9.1 Company overview
    • 8.9.2 Financial Performance
    • 8.9.3 Product benchmarking
    • 8.9.4 Strategic Initiatives
  • 8.10 OST Developpement
    • 8.10.1 Company overview
    • 8.10.2 Product benchmarking
  • 8.11 Zimmer Biomet
    • 8.11.1 Company overview
    • 8.11.2 Financial performance
    • 8.11.3 Product benchmarking
    • 8.11.4 Strategic initiatives
  • 8.12 Geistlich Pharma AG
    • 8.12.1 Company overview
    • 8.12.2 Product benchmarking
  • 8.13 TBF Tissue Engineering
    • 8.13.1 Company overview
    • 8.13.2 Product benchmarking
  • 8.14 Biobank
    • 8.14.1 Company overview
    • 8.14.2 Product benchmarking